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Introduction
The life cycle of Orthopoxviruses, such as vaccinia virus, relies 
on the dissemination of two infectious forms, the intracellular 
mature viruses (IMVs) and the extracellular viruses (EVs). 
IMVs propagate after massive release by cell lysis at the end of 
the infectious cycle. Vaccinia dissemination is also supported 
by the spread of EVs from cell to cell through actin-based mo-
tility (Smith et al., 2002; Roberts and Smith, 2008). The forma-
tion of EVs is complex and first requires wrapping of IMVs 
in double membranes derived from the trans-Golgi network or 
endosomes, leading to the production of intracellular envel-
oped viruses (IEVs; Hiller and Weber, 1985; Tooze et al., 1993; 
Schmelz et al., 1994). IEVs travel on microtubules and the 
fusion of their outer membrane to the plasma membrane leads 
to formation of cell-associated EVs (CEVs; Hollinshead et al., 
2001; Rietdorf et al., 2001; Ward and Moss, 2001a; van Eijl 
et al., 2002). The viral proteins B5 and A36 are essential for 
vaccinia actin–based motility (Sanderson et al., 1998; Wolffe 
et al., 1998; Katz et al., 2003). B5 and A36 are located in the 
inner and outer membrane of IEVs, respectively (Engelstad 
et al., 1992; Isaacs et al., 1992; Parkinson and Smith, 1994; 
Röttger et al., 1999). The fusion of the outer membrane of IEVs 
to the plasma membrane exposes B5 at the surface of CEVs 
(Engelstad et al., 1992; Isaacs et al., 1992) and positions A36 in 
the plasma membrane, underneath CEVs (van Eijl et al., 2000). 
The exact role of B5 in actin-based motility is unknown. The 
phosphorylation of the cytosolic tail of A36 by Src and Abl fam-
ily members creates docking sites for the adaptor proteins Nck1 
and Grb2 (Scaplehorn et al., 2002; Newsome et al., 2006). Nck1 
and Grb2 mediate the recruitment of N-WASP, which medi-
ates the recruitment and activation of the ARP2/3 complex 
(Frischknecht et al., 1999). The ARP2/3 complex binds existing 
mother actin filaments and nucleates the formation of daughter 
filaments that branch out from the mother filament leading to 
the formation of a branched network (Pollard and Borisy, 2003). 
The origin of the mother filaments required for initiation of 
ARP2/3-mediated actin polymerization is unknown. The as-
sembly of actin beneath CEVs generates forces that drive the 
formation of virus-tipped membrane protrusions also referred 
to as actin tails, which leads to viral release into the extracellular 
environment or viral transmission to neighboring cells (Smith 
et al., 2002; Roberts and Smith, 2008).
Vaccinia virus dissemination relies on the N-WASP–ARP2/3 pathway, which mediates actin tail for-mation underneath cell-associated extracellular 
viruses (CEVs). Here, we uncover a previously unappreci-
ated role for the formin FHOD1 and the small GTPase 
Rac1 in vaccinia actin tail formation. FHOD1 depletion 
decreased the number of CEVs forming actin tails and 
impaired the elongation rate of the formed actin tails. 
Recruitment of FHOD1 to actin tails relied on its GTPase 
binding domain in addition to its FH2 domain. In agree-
ment with previous studies showing that FHOD1 is activated 
by the small GTPase Rac1, Rac1 was enriched and acti-
vated at the membrane surrounding actin tails. Rac1 deple-
tion or expression of dominant-negative Rac1 phenocopied 
the effects of FHOD1 depletion and impaired the recruit-
ment of FHOD1 to actin tails. FHOD1 overexpression res-
cued the actin tail formation defects observed in cells 
overexpressing dominant-negative Rac1. Altogether, our 
results indicate that, to display robust actin-based motility, 
vaccinia virus integrates the activity of the N-WASP–
ARP2/3 and Rac1–FHOD1 pathways.
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Humphries et al., 2012). Thus, the cellular requirements and 
related functions supporting pathogen dissemination may prove 
to be more complex than previously depicted.
Here, we uncover the formin FHOD1 and the small GTPase 
Rac1 as novel regulators of vaccinia actin tail formation. Our 
work suggests that vaccinia virus has evolved a complex strat-
egy of actin-based motility relying on the integration of the 
activity of the ARP2/3 complex and the formin FHOD1.
Results
The formin FHOD1 is required for vaccinia 
virus dissemination
We identified the formin FHOD1 as a cellular factor required 
for vaccinia dissemination by conducting the following genetic 
approach. We first developed an assay for quantification of virus 
spread in human epithelial cells using automated fluorescence 
microscopy and computer-assisted image analysis. Wild-type 
virus expressing a B5R-GFP chimera spread from primary in-
fected cells to neighboring cells at 16 h after infection (Fig. 1, 
A and B, vB5R-GFP and control). This time point was se-
lected on the basis of preliminary time course experiments indi-
cating that at16 h after infection, vaccinia dissemination mainly 
relied on ARP2/3-dependent actin-based motility (Fig. S1 A 
http://www.jcb.org/cgi/content/full/jcb.201303055/DC1). As 
The manipulation of the actin cytoskeleton represents a 
common theme in pathogen dissemination. Similar to vaccinia 
virus, several bacterial pathogens, such as Listeria monocyto­
genes and Shigella flexneri also manipulate the ARP2/3 com-
plex in order to spread from cell to cell. L. monocytogenes 
recruits and activates the ARP2/3 complex through ActA (Welch 
et al., 1998), a bacterial factor that mimics the activity of the 
nucleation-promoting factor N-WASP (Lasa et al., 1997; Skoble 
et al., 2000; Boujemaa-Paterski et al., 2001; Chong et al., 2009). 
In contrast, S. flexneri expresses a bacterial adaptor, IcsA, that 
mediates the recruitment of N-WASP, which then recruits and 
activates the ARP2/3 complex (Bernardini et al., 1989; Goldberg 
et al., 1994; Suzuki et al., 2002). On the basis of these investiga-
tions, pathogen dissemination was thought to rely solely on the 
manipulation of the ARP2/3 complex. However, Heindl et al. 
(2010) have recently reported that, in addition to manipulating 
the ARP2/3 complex for displaying cytosolic motility, S. flexneri 
requires formin family members for plasma membrane protru-
sion formation. Moreover, recent studies have unexpectedly re-
vealed that Rickettsia spp. do not require the ARP2/3 complex 
to form actin tails and instead express and use the bacterial 
factor Sca2, a functional mimic of mammalian formins (Haglund 
et al., 2010; Kleba et al., 2010). Furthermore, a role for N-WASP 
recycling and clathrin-mediated endocytosis was recently re-
ported in vaccinia actin–based motility (Weisswange et al., 2009; 
Figure 1. Quantification of vaccinia virus spread from cell to cell. (A) Spreading of vaccinia virus expressing a B5R-GFP chimera (vB5R-GFP) in HeLa 
cells at 16 h after infection. (control) Cells infected with wild-type virus. (A36R) Cells infected with a vaccinia virus variant lacking A36R. (N-WASPsi) 
N-WASP–depleted cells infected with wild-type virus. (ARPC4si) ARPC4-depleted cells infected with wild-type virus. In N-WASP– and ARPC4-depleted cells, 
mRNA levels were consistently <20% of the levels observed in mock-treated cells. Top panels show representative images of HeLa cells (nuclei, red channel) 
infected with vaccinia virus (vB5R-GFP, green channel). Bars, 100 µm. Bottom panels display the corresponding image analysis showing large foci (white) 
and small foci (green). (B) Merged channels for the boxed areas in A showing representative foci of infection for cells infected with vB5R-GFP–expressing 
virus (control) or the variant lacking A36R (A36R). Bars, 20 µm. (C) Graph showing quantitative analysis of cell-to-cell spread. The spreading index 
represents the ratio between the number of large foci and the total number of foci. Data are presented as the mean ± SD. *, P < 0.05; **, P < 0.01; P = 
0.0015 for A36; P = 0.0064 for NWASPsi; and P = 0.0120 for ARPC4si, compared with the control.
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analyses showed that the mean spreading index was 0.36 ± 0.08 
for the wild-type virus and 0.13 ± 0.03 for the A36R variant, 
reflecting highly significant differences in the spreading ability 
of the two viral strains (Fig. 1 B). We next determined whether 
our assay would allow us to identify host factors involved in 
cell-to-cell spread by silencing the expression of N-WASP and 
ARPC4. ARPC4 is a component of the ARP2/3 complex and 
N-WASP is the nucleation-promoting factor that recruits 
and activates the ARP2/3 complex beneath CEVs. As expected, 
and similar to the deletion of A36R, depletion of N-WASP or 
ARPC4 resulted in impaired actin-based motility, as reflected by 
spreading indexes of 0.13 ± 0.03 and 0.17 ± 0.05, respectively 
(Fig. 1, A and C).
We then assembled a siRNA library covering regulators of 
the actin cytoskeleton (Siripala and Welch, 2007). The screen-
ing of this library using the assay described in Fig. 1 led to the 
identification of FHOD1 as a cytoskeleton factor required for 
vaccinia virus dissemination. We validated the specific involve-
ment of FHOD1 by using four independent silencing reagents 
expected, the recombinant A36R vaccinia variant deficient 
in actin tail formation led to the formation of infection foci of 
small size, reflecting a severe spreading defect (Fig. 1, A and B, 
A36R). We used computer-assisted image analysis to quantify 
the size of the formed foci (Fig. 1 A, bottom). The vast majority 
of the foci formed in cells infected with the A36R vaccinia 
variant displayed a size corresponding to single infected cells, 
which we defined as small (Fig. 1, A36R, green). We also ob-
served foci significantly larger in size that presumably resulted 
from the merge of two or more small foci (Fig. 1, A36R, 
white). In cells infected with wild-type viruses, we observed 
a mixed population of foci whose size ranged from small, as 
defined by the size of the foci formed in cells infected with 
the A36R vaccinia variant, to large (Fig. 1, control, green and 
white). To implement automated image analysis procedures, we 
computed the spreading index as the ratio [total foci  small 
foci]/[total foci], which accurately reflected the observed enrich-
ment in foci of large size within the population of foci formed 
in cells infected with wild-type virus (Fig. S1 B). Statistical 
Figure 2. The formin FHOD1 is required for vaccinia virus dissemination. (A) Representative images of HeLa cells (nuclei, bottom) mock treated or depleted 
of FHOD1 using four independent siRNA duplexes targeting FHOD1 expression (FHOD1siA–D) and infected with wild-type vaccinia virus expressing GFP 
(vB5R-GFP, top). Bars, 100 µm. (B) The spreading index was determined as described in Fig. 1. Data are presented as the mean ± SD of three independent 
experiments. *, P < 0.05; **, P < 0.01; P = 0.0091 for FHOD1siA; P = 0.0150 for FHOD1siB; and P = 0.0039 for FHOD1siD, compared with the mock. 
(C and D) Silencing efficiency. Cells were transfected with individual FHOD1 siRNA duplexes (siA, siB, siC, and siD) and the levels of transcripts (C) and 
protein (D) were compared with the levels detected in mock-treated cells (mock). Data for the levels of transcripts are presented as the mean ± SD of three 
independent experiments. ***, P = 0.0002 for siA and siB; ****, P < 0.0001 for siC and siD, compared with the mock.
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FHOD1 resulted in a 30% decrease in the speed of the virus 
compared with mock-treated cells (Fig. 3 D). Collectively, these 
observations indicate that FHOD1 contributes to the initiation 
and the elongation of vaccinia virus actin tails.
FHOD1 is not required for  
N-WASP recruitment
We next determined whether the decrease in actin tail formation 
observed in FHOD1-depleted cells reflected a defect in the re-
cruitment of N-WASP beneath CEVs. To this end, we analyzed 
endogenous N-WASP localization in cells infected with the re-
combinant vA5L-mCherry/3xF-B5R vaccinia variant (Fig. 4 A). 
We found that, in FHOD1-depleted cells, N-WASP was re-
cruited to CEVs as efficiently as in mock-treated cells (Fig. 4 B). 
Because we previously observed a 2.5-fold decrease in actin 
tail formation in FHOD1-depleted cells (Fig. 3 C), these results 
suggested that, as opposed to the situation observed in mock-
treated cells, a significant proportion of CEVs successfully 
recruited N-WASP and yet did not display actin tails in FHOD1-
depleted cells. To further confirm this possibility, we quantified 
the number of N-WASP–positive (A36-positive) CEVs display-
ing actin tails in mock-treated and FHOD1-depleted cells 
(Fig. 4 C). We found that >75% and <25% of N-WASP– 
positive CEVs were associated with actin tails in mock-treated 
and FHOD1-depleted cells, respectively (Fig. 4 D). These results 
indicate that FHOD1 is not required for the recruitment of 
N-WASP to CEVs, but contributes to the efficiency of N-WASP–
dependent actin tail formation.
targeting FHOD1 expression (Fig. 2, A and B, FHOD1siA–D). 
We found that siRNA duplexes A, B, and D conferred the best 
silencing efficiency at the transcriptional level (Fig. 2 C) as well 
as the translational level (Fig. 2 D). These siRNA duplexes also 
conferred the best spreading defect phenotypes (Fig. 2, A and B). 
We further showed that treatment with FHOD1 siRNA duplexes 
did not confer general cell growth defect (Fig. S2 A). Finally, we 
established that FHOD1-depleted cells could support the dis-
semination of unrelated pathogens, such as L. monocytogenes 
(Fig. S2 B). Altogether, these results indicate that the formin 
FHOD1 is specifically required for vaccinia virus dissemination.
FHOD1 stimulates actin tail initiation  
and elongation
We next determined whether the dissemination defect observed 
in FHOD1-depleted cells originated from a defect in actin-based 
motility. To this end, we infected cells with a recombinant vac-
cinia virus variant expressing an mCherry-tagged version of the 
viral core protein A5L and a triple FLAG–tagged version of B5R 
(vA5L-mCherry/3xF-B5R; Alvarez and Agaisse, 2012). FLAG 
immunostaining without permeabilization was used to detect 
and quantify the number of CEVs displaying actin tails. We 
found that depletion of FHOD1 resulted in a 2.5-fold decrease in 
the number of CEVs displaying actin tails (Fig. 3, A–C). We also 
used time-lapse microscopy to monitor vaccinia virus actin–
based motility in cells expressing YFP-N-WASP and CFP-actin. 
The velocity of N-WASP–tipped actin tails was determined in 
mock-treated or FHOD1-depleted cells. We found that silencing 
Figure 3. FHOD1 stimulates actin tail initia-
tion and elongation. (A) Representative images 
of HeLa cells infected with vA5L-mCherry/3xF-
B5R recombinant vaccinia virus. FLAG staining 
without permeabilization (green channel) was 
followed by permeabilization and staining of 
actin tails with phalloidin (blue channel). Indi-
vidual CEVs were identified by colocalization 
of A5-mCherry signal (red channel) and FLAG 
staining (green channel). Bars, 10 µm. (B) Split 
channel images of the boxed area of the 
mock-treated cell images. Closed arrowheads 
indicate CEVs that display actin tails. Open ar-
rowheads indicate CEVs that do not display 
actin tails. Bar, 3 µm. (C) Quantification of 
CEVs displaying actin tails in mock-treated 
(mock) or FHOD1-depleted (FHOD1si) HeLa 
cells. (D) Quantification of vaccinia virus veloc-
ity in mock-treated (mock) or FHOD1-depleted 
(FHOD1si) HeLa cells. Data are presented as 
the mean ± SEM. ***, P < 0.0001.
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Functional domains of FHOD1 required for 
vaccinia actin tail formation
We next investigated the determinants supporting FHOD1 
actin tail localization. The formin FHOD1 is organized into an 
N-terminal GTPase binding domain (GBD), the diaphanous 
autoregulatory domain (DAD) recognition domain FH3, a short 
proline-rich FH1 domain, an FH2 domain, and the C-terminal 
DAD (Schulte et al., 2008). The FH2 domain confers to formins 
the ability to nucleate, elongate, and cap actin filaments at 
barbed ends (Watanabe et al., 1999; Pruyne et al., 2002; Li and 
Higgs, 2003; Harris et al., 2004; Moseley et al., 2004, 2006; 
Otomo et al., 2005). These barbed end activities rely on a con-
served isoleucine residue within the FH2 domain (isoleucine 
705 in FHOD1; Harris et al., 2006). The FH1 domain is re-
quired for binding profilin-actin and may also interact with SH3 
FHOD1 localizes to vaccinia actin tails
We next analyzed the localization of FHOD1 in virus-induced 
actin tails. Immunostaining of endogenous FHOD1 revealed co-
localization with virus-tipped actin tails in infected cells 
(Fig. S3 A). To evaluate the specificity of FHOD1 recruitment 
to actin tails, we analyzed the localization of FHOD1 and mDia1 
in vaccinia-infected cells. Both FHOD1 and mDia1 belong to 
the group of diaphanous related formins and share a similar 
functional domain organization. Cells expressing GFP-FHOD1 
or GFP-mDia1 were infected with vaccinia virus and actin 
tails were scored positive or negative for the corresponding GFP 
fusion proteins. We observed that >90% of vaccinia virus actin 
tails were positive for FHOD1, whereas <25% of the tails were 
positive for mDia1 (Fig. S3 B). These results indicate that 
FHOD1 specifically localizes to vaccinia actin tails.
Figure 4. FHOD1 is not required for N-WASP recruit-
ment. (A) Representative images of HeLa cells infected 
with vA5L-mCherry/3xF-B5R recombinant vaccinia 
virus (top). Bars, 10 µm. FLAG staining without per-
meabilization (blue channel) was followed by permea-
bilization and staining of N-WASP (yellow channel). 
Individual CEVs were identified by colocalization of 
A5L-mCherry signal (red channel) and FLAG staining. 
Bottom panels correspond to split channel images 
of the boxed area of the mock-treated or FHOD1- 
depleted cell images (top). Closed arrowheads indicate 
CEVs that are positive for N-WASP localization. Open 
arrowheads indicate CEVs that are negative for 
N-WASP. Bars, 1 µm. (B) Quantification of N-WASP 
recruitment to CEV. Data are presented as the mean ± 
SEM. (C) Representative images of HeLa cells express-
ing YFP–N-WASP (yellow channel) infected with WR 
strain of vaccinia virus. Bars, 5 µm. Vaccinia virus was 
stained with an anti-A36 antibody (blue channel) and 
actin tails with phalloidin (red channel). Bottom panels 
correspond to split channel images of the boxed area 
of the mock-treated or FHOD1-depleted cell images 
(top). Co-localization of A36 and N-WASP was used 
to identify CEVs. Viruses colocalizing with N-WASP in 
mock-treated or FHOD1-depleted cells were scored as 
positive (closed arrowheads) or negative (open arrow-
heads) for actin tail formation. Bars, 1 µm. (D) Quan-
tification of N-WASP–positive CEVs displaying actin 
tails in mock-treated or FHOD1-depleted cells. Data 
are presented as the mean ± SEM. ***, P < 0.0001.
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bearing deletions of the GBD, FH1, or FH2 domains, or the 
I705A substitution within the FH2 domain could rescue actin 
tail formation in FHOD1-depleted cells. We found that the 
FHOD1 variant lacking the GBD domain was distributed in the 
cytoplasm and also in cytoplasmic vesicles in infected cells. 
This protein did not localize to the formed actin tails and failed 
to rescue the actin tail formation defect observed in FHOD1-
depleted cells (Fig. 5, A and B, FHOD1si, GBD). Expression 
of the FH1 deletion mutant showed localization to the formed 
actin tails (Fig. 5, A and B, FHOD1si, FH1). However, this 
variant failed to rescue actin tail formation (Fig. 5, A and B, 
FHOD1si, FH1). Finally, the expression of the variant carry-
ing a deletion of the FH2 domain did not localize to the formed 
actin tails and, as expected, failed to rescue actin tail formation 
(Fig. 5, A and B, FHOD1si, FH2). Similarly, the I705A substi-
tution within the FH2 domain of FHOD1 failed to rescue actin 
tail formation. However, we noticed that 60% of the formed 
or WW domain–containing proteins (Pring et al., 2003; Romero 
et al., 2004). Interaction between FH3 and DAD domains folds 
formins into an autoinhibited conformation (Alberts, 2001; 
Lammers et al., 2005; Nezami et al., 2006; Schönichen et al., 
2006). Binding of small GTPases of the Rho/Rac/Cdc42 family 
to the GBD domain relieves the autoinhibited conformation and 
leads to formin activation (Wallar and Alberts, 2003). It has 
been previously shown that FHOD1 activity requires intact 
GBD, FH1, and FH2 domains (Takeya and Sumimoto, 2003; 
Schulte et al., 2008). To further characterize the role of the func-
tional domains of FHOD1 in the formation of vaccinia virus 
actin tail formation, we first generated a full-length siRNA- 
resistant form of FHOD1 fused to dsRed. We showed that ex-
pression of this siRNA-resistant form of FHOD1 (Fig. 5, A and B, 
FHOD1si, wt) rescued the actin tail formation defect observed 
in FHOD1-depleted cells (Fig. 5, A and B, FHOD1si, –). We 
next determined whether siRNA-resistant forms of FHOD1, 
Figure 5. FHOD1 domains required for efficient actin tail formation. (A) Representative images of FHOD1-depleted cells expressing different silencing-
resistant FHOD1 cDNA variants and infected with the WR strain of vaccinia virus. Actin tails were stained with phalloidin (green channel) and the FHOD1 
cDNA variants were fused to dsRed (red channel). Bars, 10 µm. Insets show representative actin tails for FHOD1-depleted cells transfected with siRNA- 
resistant wild-type, GBD, FH1, FH2, or I705A variants of FHOD1. Bars, 1 µm. Arrowheads in the panels corresponding to transfection of the full-length 
variant of FHOD1 (wt) indicate localization of FHOD1 to actin tails. (B) Quantitative analysis of the number of actin tails per cell in mock-treated cells 
(mock, –), FHOD1-depleted cells (FHOD1si, –), or FHOD1-depleted cells expressing the different FHOD1 cDNA variants (FHOD1si, resistant FHOD1 wt, 
GBD, FH1, FH2, or I705A). Data are presented as the mean ± SEM. ***, P < 0.0001, compared with control (mock, –); **, P = 0.0043, for cells 
expressing the FH1 variant (FHOD1si, FH1).
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forming actin tails in PFN1-depleted cells (Fig. 6 E). In support 
of the specific role of PFN1 in vaccinia actin tail formation, 
L. monocytogenes displayed wild-type motility in PFN1-depleted 
cells (Serio et al., 2010; unpublished data). Altogether, these 
observations suggest that PFN1 specifically contributes to vac-
cinia dissemination through the initiation and the elongation of 
vaccinia actin tails.
Rac1 is enriched in the membrane 
surrounding actin tails
Our previous results indicated a role for the GBD domain in 
FHOD1 actin tail localization, suggesting a potential role for 
Rho/Rac/Cdc42 family members in vaccinia dissemination. 
Imaging cells expressing GFP-tagged versions of the small 
GTPases showed that Rac1-GFP localized to the plasma mem-
brane (Fig. 7 A) and was apparently enriched at the membrane 
surrounding actin tails (Fig. 7 A). In contrast, Cdc42-GFP was 
very weakly recruited to CEVs and Rho-GFP was not recruited at 
all (unpublished data). We next quantified the enrichment of 
Rac1-GFP at the plasma membrane surrounding actin tails. 
Computer-assisted image analysis of Rac1-GFP signal levels 
(Fig. 7 A [bottom] and B) showed that membrane projections 
corresponding to actin tails displayed a 100% increase compared 
actin tails displayed this mutant version of FHOD1 (Fig. 5, A 
and B, FHOD1si, I705A). Altogether, these results indicate that 
the functional domains of the formin FHOD1 are required for 
vaccinia actin tail formation.
Profilin-1 promotes the initiation and the 
elongation of vaccinia actin tails
Our results indicated a role for the FH1 domain of FHOD1 in 
vaccinia actin tail formation, suggesting that binding of profilin-
actin to the FH1 domain of FHOD1 might be required for 
FHOD1 function in actin tail formation. To investigate this pos-
sibility, we first analyzed the role of Profilin-1 (PFN1) in vac-
cinia dissemination by using the spreading assay presented in 
Fig. 1. Using four independent siRNA duplexes targeting PFN1 
expression, we found that PFN1 depletion impaired vaccinia 
dissemination (Fig. 6, A and B, PFN1siA–D). The efficiency of 
the silencing reagents was confirmed at the transcriptional level 
(Fig. 6 C). To determine whether the observed spreading defect 
was related to a defect in actin tail formation, we quantified 
the number of CEVs displaying actin tails in mock-treated and 
PFN1-depleted cells. PFN1 depletion resulted in a 2.5-fold 
decrease in the number of CEVs with actin tails (Fig. 6 D). In 
addition, we recorded a 30% decrease in the speed of the viruses 
Figure 6. Profilin 1 stimulates actin tail initiation and elongation. (A) Representative images of HeLa cells (nuclei, bottom) mock treated or depleted of 
Profilin 1 (PFN1) using four independent siRNA duplexes targeting PFN1 expression (PFN1siA–D) and infected with wild-type vaccinia virus expressing 
GFP (vB5R-GFP, top). Bars, 100 µm. (B) The spreading index was determined as described in Fig. 1. Data are presented as the mean ± SD of three 
independent experiments. *, P < 0.05; **, P < 0.01; P = 0.0194 for PFN1siA; P = 0.0417 for PFN1siB; P = 0.0040 for PFN1siC; and P = 0.0093 for 
PFN1siD, compared with the mock. (C) Silencing efficiency. Cells were transfected with individual PFN1 siRNA duplexes (siA, siB, siC, and siD) and were 
compared with mock-treated cells (mock) for silencing efficiency at the transcript level. (D) Quantification of CEVs displaying actin tails in mock-treated 
(mock) or PFN1-depleted (PFN1si) HeLa cells. Data are presented as the mean ± SEM. (E) Quantification of CEV actin-based motility. Data are presented 
as the mean ± SEM. ***, P < 0.0001.
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viruses colocalizing with phospho-Src (P-Src) displayed a 75% 
increase in dsRed-Rac1 signal levels compared with the levels 
recorded locally at the plasma membrane (Fig. 7 F). Altogether, 
these results indicate that signaling events triggered by CEVs at 
the plasma membrane lead to the A36-independent recruitment 
of the small GTPase Rac1.
Rac1 stimulates actin tail initiation  
and elongation
We next determined the functional significance of Rac1 recruit-
ment to the plasma membrane surrounding actin tails. We first 
used the spreading assay presented in Fig. 1 and quantified the 
dissemination of vaccinia virus in Rac1-depleted cells. We 
found that, similar to the situation observed in FHOD1-depleted 
cells, vaccinia spread from cell to cell was impaired in Rac1-
depleted cells (Fig. 8 A). We validated the specific involvement 
of Rac1 by using four independent silencing reagents targeting 
with the signal displayed locally at the plasma membrane 
(Fig. 7 C). Furthermore, we determined that the p21 binding 
domain (PBD)–PAK1 probe, which binds activated Rac1 
(Hoppe and Swanson, 2004), was also enriched in vaccinia 
actin tails (Fig. S4). Thus, CEVs trigger signaling events at 
the plasma membrane that lead to the local recruitment and 
activation of Rac1.
We also investigated whether Rac1 recruitment relied on 
the A36–N-WASP–ARP2/3 pathway. To this end we quantified 
Rac1 enrichment in cells infected with A36-deficient viruses 
(Fig. 7 D, vA36R). Even though vA36R viruses did not form 
actin tails, they displayed active tyrosine kinase signaling and 
colocalized with phosphorylated Src (Fig. 7 D, P-Src), as pre-
viously reported for the A36R mutant defective for phosphory-
lation on tyrosine residues 112 and 132 (Newsome et al., 2004). 
Computer-assisted image analyses (Fig. 7, D [bottom] and E) 
revealed that the membrane located beneath A36-deficient 
Figure 7. Rac1 is enriched in the membrane sur-
rounding actin tails. (A) Representative confocal 
image of a cell expressing Rac1-GFP (green channel) 
infected with the WR strain of vaccinia virus. Actin 
tails were stained with phalloidin (red channel). Bars, 
10 µm. (top) The insets show Rac1 localization at the 
plasma membrane surrounding actin tails. Bars, 1 µm. 
Asterisks indicate examples of Rac1-positive actin tails. 
Dashed lines indicate the Y coordinates corresponding 
to the XZ reconstructions shown in the middle panels. 
Bars, 10 µm. Bottom panels correspond to images of 
the boxed area showing that Rac1 is enriched around 
vaccinia actin tails. Bars, 1 µm. (B) Green channel 
intensities measured along a line crossing vaccinia 
actin tails (A and B, blue line) or crossing the plasma 
membrane adjacent to the actin tails (A and B, red 
line). (C) Quantification of Rac1 enrichment in the 
membrane surrounding actin tails. Rac1 enrichment 
represents the ratio between the maximum intensities 
for the line crossing the actin tail (B, blue arrowhead) 
and the line crossing the plasma membrane (B, red 
arrowhead). (D) Representative confocal image of a 
cell expressing Rac1-dsRed (dsRed Rac1, red chan-
nel) infected with the vGFP-A36R variant of vaccinia 
virus (vA36R, yellow channel) and stained with a 
P-Src–specific antibody (P-Src, blue channel). Bars, 10 µm. 
(top, inset) A36R-deficient viruses positive for P-Src 
staining are indicated with closed arrowheads and 
viruses negative for P-Src staining are indicated with 
open arrowheads. P-Src–positive viruses showed Rac1 
recruitment. Bars, 1 µm. Dashed lines indicate the Y 
coordinates corresponding to the XZ reconstructions 
shown in the middle panels. Bars, 10 µm. Bottom pan-
els correspond to images of the boxed area showing 
that Rac1 is enriched beneath P-Src–positive viruses. 
Bars, 1 µm. (E) Red channel intensities measured 
along a line crossing P-Src–positive viruses (D and E, 
blue line) or crossing the plasma membrane adjacent 
to the virus (D and E, red line). (F) Quantification of 
Rac1 enrichment beneath P-Src–positive viruses. Rac1 
enrichment represents the ratio between the maximum 
intensities for the line crossing a P-Src–positive virus 
(B, blue arrowhead) and the line crossing the plasma 
membrane (B, red arrowhead).
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localized to actin tails and were required for their formation. 
Altogether these results led us to hypothesize that the recruit-
ment of Rac1 to CEVs mediated the recruitment and activation 
of FHOD1. To test this hypothesis, we analyzed the localization 
of FHOD1 in Rac1-depleted cells expressing dsRed-FHOD1. 
We noticed that the overall level of dsRed-FHOD1 expression 
was systematically lower in Rac1-depleted cells, suggesting 
that Rac1 may regulate the overall level of FHOD1 expression 
through an unknown mechanism. In mock-treated and Rac1- 
depleted cells expressing comparable levels of dsRed-FHOD1 
(Fig. 8 A), we determined that 50% of the actin tails formed in 
Rac1-depleted cells did not colocalize with FHOD1 (Fig. 8 B), 
indicating that Rac1 activity contributes to the localization of 
FHOD1 to actin tails.
As an alternative approach and to confirm the specific role 
of Rac1 in FHOD1 recruitment, we used a dominant-negative 
version of Rac1 (Rac1N17). This construct is thought to display 
its dominant-negative effect through stable interaction with and 
titration of the guanine nucleotide exchange factors involved 
in Rac1 activation (Feig, 1999). We compared the effect of ex-
pressing dominant-negative versions of Rho, Cdc42, and Rac1 
small GTPases on vaccinia actin tail formation. In agreement 
Rac1 expression (Fig. 8, A and B, Rac1siA–D). We found that 
all four siRNA duplexes conferred efficient silencing at the tran-
scriptional level (Fig. 8 C). All four siRNA duplexes also con-
ferred spreading defect phenotypes (Fig. 8, A and B). With the 
exception of Rac1 siRNA duplex A, treatment with Rac1 siRNA 
duplexes did not confer general cell growth defect (Fig. S5 A). 
We also established that Rac1-depleted cells supported L. mono­
cytogenes spread from cell to cell (Fig. S5 B). Similar to the 
impact of FHOD1 depletion on actin tail formation, we found 
that Rac1 depletion resulted in a 2.5-fold reduction in the num-
ber of CEVs displaying actin tails and a 25% decrease in the 
speed of vaccinia actin-based motility (Fig. 8, D and E). Alto-
gether, these results indicate that the small GTPase Rac1 is spe-
cifically required for vaccinia virus dissemination through 
stimulation of initiation and elongation of actin tails.
The localization of FHOD1 to actin tails 
relies on Rac1
Previous studies have established that Rac1 is specifically involved 
in FHOD1 activation at the plasma membrane (Westendorf, 
2001; Gasteier et al., 2003; Schulte et al., 2008). Our results on 
vaccinia dissemination indicated that Rac1 and FHOD1 both 
Figure 8. Rac1 stimulates actin tail initiation and elongation. (A) Representative images of HeLa cells (nuclei, bottom) mock treated or depleted of RAC1 
using four redundant siRNAs targeting Rac1 expression (Rac1siA–D) and infected with wild-type vaccinia virus expressing GFP (vB5R-GFP, top). Bars, 
100 µm. (B) The spreading index was determined as described in Fig. 1. Data are presented as the mean ± SD of three independent experiments. *, P < 
0.05; **, P < 0.01; P = 0.0073 for Rac1siA; P = 0.0382 for Rac1siB; P = 0.0140 for Rac1siC; and P = 0.0199 for Rac1siD, compared with the mock. 
(C) Silencing efficiency. Cells were transfected with individual Rac1 siRNA duplexes (siA, siB, siC, and siD) and were compared with mock-treated cells 
(mock) for silencing efficiency at the transcript level. Data are presented as the mean ± SD. ****, P < 0.0001; ***, P < 0.001; **, P < 0.01. P < 0.0001 
for siA; P = 0.0005 for siB; P = 0.0047 for siC; and P = 0.0011 for siD, compared with the mock. (D) Quantification of CEVs displaying actin tails in 
mock-treated (mock) or Rac1-depleted (Rac1si) HeLa cells. Data are presented as the mean ± SEM. **, P = 0.0019. (E) Quantification of CEV actin-based 
motility. Data are presented as the mean ± SEM. ***, P < 0.0001.
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Interestingly, we found that overexpression of both full-length 
FHOD1 or a variant bearing a deletion of the C-terminal DAD 
domain rescued to wild-type levels the actin tail formation 
defects observed in cells expressing dominant-negative Rac1 
(Fig. 9, C and D, DN Rac1 + FHOD1wt and DN Rac1 + 
FHOD1DAD). As expected, overexpression of the FHOD1 
variant bearing a deletion of the FH2 domain did not rescue the 
defect observed in cells expressing dominant-negative Rac1 
(Fig. 9 D, DN Rac1 + FHOD1FH2). Moreover, overexpres-
sion of components involved in the activation of the ARP2/3 
complex, such as N-WASP, could not rescue actin tail formation 
in cells expressing DN Rac1 (Fig. 9 D, DN Rac1 and DN Rac1 + 
NWASP). Altogether, these results support the notion that Rac1 
specifically regulates the activity of FHOD1 in vaccinia actin 
tail formation.
with previous observations (Arakawa et al., 2007), the number 
of actin tails formed in cells expressing dominant-negative Rho 
was similar to the number observed in mock-treated cells 
(Fig. 9 D, control and DN Rho). In contrast, expression of dom-
inant-negative Rac1 resulted in a threefold decrease in the num-
ber of actin tails (Fig. 9, C [top] and D [control and DN Rac1]). 
Expression of dominant-negative Cdc42 resulted in a twofold 
decrease in the number of actin tails (Fig. 9 C [top] and D 
[control and DN Cdc42]). Because previous studies in Cdc42 
null cells (Shibata et al., 2002) and Cdc42 depletion by RNAi 
(unpublished data) indicated that Cdc42 is not required for 
vaccinia actin tail formation, these results suggested that over-
expression of the dominant-negative version of Cdc42 prob-
ably affected vaccinia actin tail formation by titrating the 
guanine nucleotide exchange factor involved in Rac1 activation. 
Figure 9. Rac1 stimulates FHOD1 recruitment to actin tails. (A) Representative images of HeLa cells transfected with dsRed-FHOD1 and infected with WR 
strain of vaccinia. Bars, 10 µm. Localization of FHOD1 (red channel) to actin tails (green channel) was assessed in mock-treated (mock) or Rac1-depleted 
(Rac1si) cells. The inset in the top panels (mock) shows a representative actin tail decorated with FHOD1. Bars, 1 µm. Closed arrowheads indicate ex-
amples of FHOD1-positive actin tails. The inset in the bottom panels (Rac1si) shows a representative FHOD1-negative actin tail. (B) Quantitative analysis of 
FHOD1 localization to actin tails in mock-treated and Rac1-depleted cells. Data are presented as the mean ± SEM. ***, P < 0.0001. (C) Representative 
images of HeLa cells infected with the WR strain of vaccinia virus. Control cells were stained with phalloidin (red channel) to visualize actin tails. Dominant-
negative Rac1 (DN Rac1) cells were transfected with GFP-Rac1 N17 (green channel) the day before infection and stained with phalloidin (red channel) to 
visualize actin tails. DN-Rac1 + FHOD1 cells were cotransfected with GFP-Rac1 N17 (blue channel) and dsRed-FHOD1-DAD (red channel) the day before 
infection and stained with phalloidin (yellow channel) to visualize actin tails. Bars, 10 µm. (D) Quantitative analysis of the number of actin tails per cell 
in control cells (control), cells expressing dominant-negative versions of the small GTPases Rho N19 (DN-Rho), Cdc42 N17 (DN-Cdc42), and Rac1 N17 
(DN-Rac1), or cells coexpressing DN-Rac1 + NWASP, DN-Rac1 + FHOD1wt, DN-Rac1 + FHOD1-DAD, or DN-Rac1 + FHOD1-FH2. ***, P < 0.0001, 
compared with control; **, P = 0.0022, for cells expressing DN-Cdc42.
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that the localization of FHOD1 to vaccinia actin tails relies 
on the small GTPase Rac1 and the nucleation-promoting fac-
tor N-WASP.
Discussion
A formin in vaccinia actin tail formation
Although the central role of the ARP2/3 complex and associ-
ated regulatory proteins, such as N-WASP, has been demon-
strated by unambiguous genetic approaches, it was unclear 
whether additional cytoskeleton regulators may also play previ-
ously unappreciated roles in vaccinia dissemination. Here, we 
developed high-throughput imaging and computer-assisted 
image analyses procedures in combination with the RNAi meth-
odology to identify cytoskeleton factors required for vaccinia 
spread from cell to cell, an approach that led to the identification 
of a formin, FHOD1. Formin family members harbor a con-
served FH2 domain that mediates barbed end activities, including 
nucleation, capping, and/or elongation of actin filaments. Our 
The localization of FHOD1 to actin tails 
requires N-WASP
Our previous results suggested that, in addition to the N-WASP–
ARP2/3 pathway, vaccinia virus exploits the Rac1–FHOD1 
pathway for efficient actin tail formation. To further character-
ize the interplay between these two pathways, we quantified the 
recruitment of N-WASP to CEVs in Rac1-depleted cells. Simi-
lar to the results observed in FHOD1-depleted cells (Fig. 4), we 
found that N-WASP recruitment to CEVs was similar in mock-
treated and Rac1-depleted cells (Fig. 10 A, mock and Rac1si). 
These results therefore indicated that the Rac1–FHOD1 path-
way was not required for N-WASP recruitment. Conversely, we 
tested whether N-WASP may be required for FHOD1 recruit-
ment. To this end, we infected dsRed-FHOD1–expressing cells 
with wild-type virus expressing a B5R-CFP chimera. We found 
that >70% of the viruses positive for P-Src recruited FHOD1 
in mock-treated cells (Fig. 10, B–D). In contrast, <20% of 
P-Src–positive viruses recruited FHOD1 in N-WASP–depleted 
cells (Fig. 10, B–D). Collectively, our observations indicate 
Figure 10. N-WASP–dependent recruitment 
of FHOD1 and model of vaccinia actin tail ini-
tiation and elongation. (A) Quantification of 
N-WASP recruitment to CEV in mock-treated 
and Rac1-depleted cells. Data are presented 
as the mean ± SEM. (B) Representative images 
of HeLa cells expressing dsRed-FHOD1 (red 
channel) infected with the vB5R-CFP variant 
of vaccinia virus (B5-CFP, blue channel) and 
stained with a P-Src–specific antibody (P-Src, 
yellow channel). Bars, 10 µm. (C) Split channel 
images of the boxed area of the mock-treated 
(mock) or N-WASP–depleted cells (NWASPsi) 
from A. Localization of FHOD1 to P-Src– 
positive viruses was assessed in mock-treated 
(mock) or N-WASP–depleted (NWASPsi) 
cells. Closed arrowheads indicate examples 
of FHOD1-positive viruses. Open arrowheads 
show FHOD1-negative viruses. Bars, 1 µm. 
(D) Quantitative analysis of FHOD1 localiza-
tion to P-Src–positive viruses in mock-treated 
and N-WASP–depleted cells. Data are pre-
sented as the mean ± SEM. ***, P < 0.0001. 
(E) Model of vaccinia actin-based motility. The 
cytoplasmic domain of A36 is phosphorylated 
underneath CEVs (white and gray oval) by ty-
rosine kinases of the Src family leading to the 
recruitment of adaptor proteins (gray circles) 
that in turn recruit N-WASP and the ARP2/3 
complex. N-WASP is required for the recruit-
ment of FHOD1 through an unknown mecha-
nism (left, question mark). Activation of Rac1 
also contributes to the recruitment and activa-
tion of FHOD1, which may prime the forma-
tion of actin tails by nucleating the assembly of 
actin filaments (left). The actin filaments primed 
by FHOD1 are used as mother filaments by 
the ARP2/3 complex, which nucleates the as-
sembly of daughter filaments (right). FHOD1 
binds to the barbed ends of daughter filaments 
(right), as well as mother filaments (left), and 
increases their rate of elongation in a PFN1-
dependent manner (not depicted).
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in vaccinia actin tail formation. The interaction between the 
FH3 and the DAD domains maintains formins in an autoinhib-
ited conformation, which is relieved upon interaction of the 
GBD domain with activated small GTPases of the Rho family 
(Li and Higgs, 2003; Lammers et al., 2005). Previous studies 
determined that FHOD1 preferentially interacts with the small 
GTPase Rac1 (Gasteier et al., 2003; Schönichen et al., 2006; 
Schulte et al., 2008). We now provide several lines of evidence 
supporting the notion that Rac1 mediates vaccinia actin tail for-
mation through the recruitment and activation of FHOD1, inde-
pendently from the N-WASP–ARP2/3 pathway. We demonstrate 
that Rac1 is required for FHOD1 recruitment (Fig. 9), but not 
for N-WASP recruitment (Fig. 10). Moreover, we show that the 
actin tail formation defects observed in cells expressing domi-
nant-negative Rac1 are specifically rescued by overexpression 
of FHOD1, but not by overexpression of a mutant version of 
FHOD1 lacking the FH2 domain or by overexpression of the 
wild-type version of N-WASP. Although Rac1 is apparently not 
required for N-WASP recruitment, N-WASP is nonetheless 
required for FHOD1 recruitment (Fig. 10 D). We speculate that 
adaptor proteins such as WISH, which binds FHOD1 (Westendorf 
and Koka, 2004) and N-WASP (Fukuoka et al., 2001), may con-
tribute to the N-WASP–dependent recruitment of FHOD1.
Because our results indicated that Rac1 was enriched and 
activated at the plasma membrane surrounding vaccinia actin 
tails, we tested the possibility that, similar to N-WASP, the 
recruitment and activation of Rac1 may rely on the viral protein 
A36. However, P-Src–positive, A36-deficient CEVs recruited 
Rac1 as efficiently as wild-type viruses, indicating that Rac1 
recruitment did not rely on the viral protein A36. Thus, the sig-
naling events leading to the recruitment and activation of Rac1 
beneath CEVs remain to be determined. We speculate that, in 
addition to mediating A36 phosphorylation, Src-mediated tyro-
sine kinase signaling mediates Rac1 activation, which in turn 
leads to the recruitment and activation of FHOD1 (Fig. 10 E). 
In agreement with this notion, Src was shown to regulate the 
activity of FHOD1 in unrelated systems (Koka et al., 2005; 
Hannemann et al., 2008).
In conclusion, we propose that vaccinia virus evolved 
the ability to display robust actin-based motility by manipulat-
ing not only the N-WASP–mediated activation of the ARP2/3 
complex but also the Rac1-mediated activation of FHOD1 
(Fig. 10 E).
Materials and methods
Cells and viruses
HeLa (American Type Culture Collection), HeLa S3 (American Type Culture 
Collection), and BS-C-1 (American Type Culture Collection) cells were 
grown in DMEM (Invitrogen) supplemented with 10% FBS (Gibco) at 37°C 
in a 5% CO2 incubator. Vaccinia virus strains WR, vB5R-GFP (Ward and 
Moss, 2001b), B5R-GFP/deltaA36R (Ward and Moss, 2001a), and the 
B5R deletion mutant vSI-14 (Wolffe et al., 1993) were provided by B. Moss 
(National Institute of Allergy and Infectious Diseases, Bethesda, MD). The 
recombinant vA5L-mCherry/3xF-B5R virus carrying an N-terminal fusion of 
A5L to mCherry and a triple FLAG-tagged version of B5R was previously 
described (Alvarez and Agaisse, 2012). Viral strains were grown and 
propagated in HeLa cells and plaque assays were performed in BS-C-1 
cells according to standard procedures (Earl et al., 2001). In brief, 6-well 
plates were seeded with 5 × 105 BS-C-1 cells per well and infected on the 
results demonstrate that the FH2 domain of FHOD1 plays a criti-
cal role in the initiation and the elongation of actin tails, suggest-
ing that FHOD1 supports vaccinia actin tail formation through 
nucleation and elongation of actin filaments. In further support 
of the role of FHOD1 through its elongation activity, we show 
that actin tail formation requires the FH1 domain of FHOD1 and 
its binding partner PFN1, which stimulates the elongation activ-
ity of formins (Romero et al., 2004; Kovar et al., 2006). We note 
that a recent study reported that, unlike other formin family mem-
bers, FHOD1 displays capping and bundling activities, but very 
low elongation and no nucleation activities in vitro (Schönichen 
et al., 2013). Because our results strongly support the notion that 
FHOD1 does display nucleation and elongation activities in the 
context of vaccinia actin tail formation in vivo, we suggest that 
the apparent absence of nucleation and elongation activities ob-
served in vitro reflects the in vivo complexity of FHOD1 regula-
tion (see Regulation of FHOD1 activity in actin tail formation).
Respective role of FHOD1 and ARP2/3 in 
actin tail formation
Because FHOD1 depletion did not affect the numbers of CEVs 
positive for N-WASP, it is unlikely that FHOD1 regulates actin tail 
formation through regulation of the N-WASP–ARP2/3 pathway. 
Instead, our results are in agreement with the notion that, in addi-
tion to the nucleation activity displayed by the ARP2/3 complex, 
the nucleation activity of FHOD1 is required for efficient initiation 
of actin tail formation. Because the ARP2/3 complex requires 
mother filaments to nucleate daughter filaments, we speculate that 
FHOD1 primes the process of actin tail formation by nucleating the 
assembly of actin filaments that constitute mother filaments for the 
ARP2/3 complex (Fig. 10 E, left). We, however, note that the prim-
ing process is probably not absolutely required because tail for-
mation is reduced in FHOD1-depleted cells, but not abolished. 
Alternatively, the decrease in the numbers of CEVs displaying 
actin tails may in fact reflect efficient disassembly of tails that do 
not elongate properly. In addition to a role in regulating actin tail 
initiation, our results indicate that FHOD1 also plays a role in regu-
lating actin tail elongation. Because formins bind to the barbed 
ends of actin filaments and increase their rate of elongation (Romero 
et al., 2004; Kovar et al., 2006), our observations are therefore con-
sistent with the notion that FHOD1 may increase the rate of actin 
tail elongation by increasing the rate of actin filament elongation 
after ARP2/3-mediated nucleation of daughter filaments (Fig. 10 E, 
right). Such a cooperation between the ARP2/3 complex and 
formins is not unprecedented and was recently described in lamel-
lipodia for ARP2/3 and the formin FMNL2 (Block et al., 2012). In 
this study, the activity of the formin was regulated by the small 
GTPase Cdc42 at the plasma membrane and facilitated the elonga-
tion of filaments nucleated by the ARP2/3 complex. Thus, the co-
operation between the ARP2/3 complex and formins constitutes an 
emerging theme in actin-based motility, as suggested by our pres-
ent study on the role of FHOD1 in vaccinia actin tail formation.
Regulation of FHOD1 activity in actin  
tail formation
In addition to the expected requirement for the FH2 domain, we 
found that the GBD domain of FHOD1 plays an important role 
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were washed with PBS, fixed in ice-cold 3% paraformaldehyde in PBS, and 
washed twice with PBS. To detect CEVs at the cell surface, cells infected 
with vA5L-mCherry/3xF-B5R were fixed and then blocked in 10% BSA/
PBS, stained in 2% BSA/PBS containing mouse M2 monoclonal antibody 
anti-FLAG (1:1,000; Sigma-Aldrich) for 30 min, and washed five times in 
2% BSA in PBS before addition of secondary antibody. To visualize actin 
tails, cells were permeabilized in 0.1% Triton X-100 in PBS and stained 
with phalloidin. Actin tails were identified as bright objects in the phalloi-
din staining and were required to be at least 2 µm long. To quantify local-
ization of N-WASP to CEVs, cells were first stained for surface FLAG, then 
blocked and permeabilized in 10% BSA/0.1% Triton X-100 in PBS, and 
stained with anti–N-WASP rabbit mAb (1:200; Cell Signaling Technology). 
Rabbit polyclonal antibody against A36RC (1:1,000) was provided by 
B. Moss. P-Src was stained with a mouse monoclonal antibody anti-P-Src 
(Tyr416; 1:200) obtained from EMD Millipore. Alexa Fluor secondary 
antibodies (1:1,000) and Alexa Fluor–conjugated phalloidin (1:500) were 
obtained from Invitrogen. Coverslips were mounted onto glass slides using 
FluoroGuard Antifade Reagent (Bio-Rad Laboratories) and imaged using 
a TE 2000 microscope (Nikon) equipped with a digital CCD camera 
(Orca ER), motorized stage, motorized filter wheels, and a 60× objective 
(NA 0.85; Nikon) mounted on a piezo focus drive system. Image acqui-
sition and analysis was conducted using the MetaMorph 7.1 software. 
Quantitative analysis of CEV formation in cells infected with the recombi-
nant vA5L-mCherry/3xF-B5R virus was conducted as previously described 
(Alvarez and Agaisse, 2012). In brief, appropriate threshold and size fil-
tering of red channel to identify objects corresponding to virus cores ex-
pressing A5-mCherry generated a mask displaying only single virus 
particles. The same analysis was performed for the FLAG staining channel 
to identify objects corresponding to FLAG-B5–expressing CEVs. Finally we 
used logical AND in the arithmetic function to define and count CEVs as 
objects corresponding to colocalization of A5-mCherry and FLAG-B5 sig-
nals. The quantification of percentage localization with CEVs was per-
formed by visual inspection.
Plasmid construction
The pCMV5-HA-FHOD1 construct was a gift from O. Fackler (University 
Hospital Heidelberg, Heidelberg, Germany; Madrid et al., 2005). Full-
length FHOD1 was amplified from pCMV5-HA-FHOD1 using primers (18) 
and (19) and cloned into pEGFP-C1 (Takara Bio Inc.) between EcoRI and 
BamHI restriction sites. To generate an siRNA-resistant form of FHOD1, a 
PCR fragment containing silent mutations in the target sequence for FHOD1 
siRNA B (Table S1) was generated by fusion of the PCR products amplified 
with primers EFGP C and (31) and primers (32) and (19) using pEGFP-
FHOD1 as a template. This was cloned into pdsRed-C1 between XhoI and 
BamHI restriction sites to yield siRNA-resistant pdsRed-FHOD1. The corre-
sponding GBD domain deletion construct was obtained by cloning the PCR 
product amplified with primers (58) and FHOD1rev between XhoI and 
HindIII restriction sites. To construct the FH1 domain deletion, the PCR prod-
ucts obtained with primers (32) and (55) and primers (54) and (19) were 
fused together and cloned into pdsRed-FHOD1 between HindIII and BamHI 
restriction sites. The FH2 domain deletion was generated following the 
same cloning strategy after fusing together the PCR products generated 
with primers (32) and (36) and primers (35) and (19). Similarly, the PCR 
products obtained using primers (32) and (71) and primers (70) and (19) 
were fused together to generate the Ile to Ala substitution at amino acid 
position 705. The deletion of amino acids 1005–1064 comprising the 
DAD domain was generated using primers (32) and (73).
The wild-type and dominant-negative versions of Rho, Rac, and 
Cdc42 cDNA were described previously (Ridley et al., 1992; Bagrodia 
et al., 1995; Qiu et al., 1995). Dominant-negative RhoN19, RacN17, and 
Cdc42N17 small GTPases carry a Thr to Asn substitution at the indicated 
amino acid position. The corresponding GFP fusions were expressed from 
pEGFP-C1 vector and were provided by J. Galán (Yale University, New 
Haven, CT). The dsRed-Rac1 construct was obtained by subcloning the 
BspEI–BamHI fragment from pEGFPC1-Rac1 (Krall et al., 2002) into 
pDsRed-Monomer-C1. The PBD of PAK1 was amplified by PCR using primers 
(66) and (67) and cloned into pdsRed-N1 between XhoI and HindIII restric-
tion sites. N-WASP ORF was amplified from HeLa cell cDNA with primers 
(37) and (38) and cloned into pYFP-C1 between XhoI and EcoRI. Actin-CFP 
was derived from actin-GFP plasmid (Rolls et al., 1999). The oligonucle-
otide sequences of the primers used in this study are listed in Table S2.
Plasmid transfection
Mock- and siRNA-treated HeLa cells were seeded on glass coverslips in 
24-well format on day 0. DNA constructs were transfected with X-tremeGENE 
next day with 10-fold serial dilutions of the virus stocks prepared in DMEM 
supplemented with 2.5% FBS. 2 d after infection cells were stained with 
0.1% crystal violet and the virus titer was determined by plaque counting. 
Virus stocks were prepared from HeLa S3 cells and partially purified by 
centrifugation through a 36% sucrose cushion (Earl et al., 2001).
Vaccinia spreading assay
The procedure for siRNA setup in 384-well plates was described previously 
(Chong et al., 2011). In brief, 10 µl of individual siRNAs (200 nM) were 
aliquoted in 384-well plates. 10 µl of Dharmafect 1 transfection mixture (5 µl 
of Dharmafect 1 per 1 ml of serum-free DMEM) was dispensed per well 
and incubated for 20 min at room temperature. HeLa cells were lifted and 
resuspended at 100,000 cells/ml in DMEM supplemented with 10% FBS. 
20 µl of the cell suspension were delivered to each well, and the plates 
were then incubated for 3 d at 37°C, in 5% CO2. siRNA-treated cells were 
infected at 0.01 pfu per cell with 10 µl of a dilution of vaccinia virus vB5R-GFP 
stock. The plates were centrifuged at 2,000 rpm for 10 min and infection 
was allowed to proceed for 16 h. Infected cells were fixed in 4% parafor-
maldehyde in PBS and then stained with Hoechst 33348 (Molecular 
Probes), washed in PBS, and imaged.
High-throughput imaging and computer-assisted image analysis
384-well plates were imaged using a microscope (TE 2000; Nikon) 
equipped with a digital CCD camera (Orca ER; Hamamatsu Photonics), 
motorized stage (Prior), motorized filter wheels (Sutter Instrument), and a 
10× objective (NA 0.45; Nikon) mounted on a piezo focus drive system 
(Physik Instrumente). Image acquisition and analyses were conducted using 
the MetaMorph 7.1 software (Molecular Devices). Appropriate threshold 
of green channel identified objects corresponding to vB5R-GFP–infected 
cells (Fig. S1 B, threshold). We next used the image morphometry analysis 
module and the dilate function in the morphology filters to generate a mask 
displaying foci of infection (Fig. S1 B, segmentation). This mask was used 
as the source image to count and classify foci of infection according to 
their size into large and small foci (Fig. S1 B, classifier). The spreading 
index was calculated as the ratio [total foci  small foci]/[total foci] for a 
given well.
Construction of vB5R-CFP virus
A plasmid containing B5R fused to CFP and 500 bp of flanking sequence 
on each side was constructed by excision of the ECFP ORF from pECFP-N1 
(Takara Bio Inc.) with NcoI and NotI restriction enzymes and subcloning 
into pBMW10 (Ward and Moss, 2001b), provided by B. Ward (University 
of Rochester, Rochester, NY). The B5R-CFP fusion plasmid was transfected 
with X-tremeGENE 9 (Roche) into HeLa cells that had been infected with the 
vaccinia virus B5R deletion mutant vSI-14 (Wolffe et al., 1993). Recom-
binant viruses that formed cyan fluorescent foci were plaque purified three 
times. The resulting recombinant vB5R-CFP was analyzed by PCR. Primers 
(13) and (16) amplified a 2.3-kb DNA product in agreement with the insertion 
of the B5R-CFP ORF.
Silencing and validation procedures
Cells were transfected by reverse transfection with Dharmafect1 (Thermo 
Fisher Scientific) and individual siRNAs (50 nM final) or a pool of the four 
silencing reagents (12.5 nM each, 50 nM total) and were incubated for 
72 h in a 24-well plate format. The sequences targeted by the individual 
siRNA duplexes are listed in Table S1.
For real-time PCR analysis, total RNA and first-strand cDNA synthe-
sis was performed using the TaqMan Gene Expression Cells-to-Ct kit 
(Applied Biosystems), as recommended by the manufacturer, with the ad-
dition of DNaseI for the removal of unwanted genomic DNA. mRNA levels 
were determined by quantitative real-time PCR using the LightCycler 
480 Master kit and LightCycler 480 instrument (Roche). The probes and 
primers were designed according to Roche recommendation.
For Western blot analysis, cells were transfected with the correspond-
ing silencing reagents in a 24-well plate format and lysed directly in Laemmli 
sample buffer. The anti-FHOD1 antibody (1:1,000) was obtained from Novus 
Biologicals. The anti-actin antibody (1:10,000) was obtained from Sigma- 
Aldrich. The anti-rabbit HRP-conjugated secondary antibody (1:10,000) was 
obtained from Jackson ImmunoResearch Laboratories, Inc.
Immunofluorescence procedures
HeLa cells were seeded on glass coverslips, grown to 30–50% confluency, 
and infected with vaccinia virus at 10 pfu per cell. For vaccinia infection, 
cells were incubated with the virus inoculum for 1 h, and then washed three 
times with PBS before adding fresh media. At 10 h after infection cells 
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9 (Roche) on day 2. On day 3, cells were infected with vaccinia virus as 
described for immunofluorescence procedures, fixed, and processed for 
imaging using a spinning disc confocal microscope (TE2000E; Nikon).
Rac1 enrichment quantification
Cells expressing Rac1-GFP were infected with WR strain of vaccinia virus. 
At 10 h after infection cells were fixed and stained with phalloidin. Images 
were acquired on a spinning disc confocal microscope (TE2000E) and 
a 60× oil objective (NA 1.4) using the Volocity software (PerkinElmer). 
Rac1 enrichment in actin tails was quantified on XZ reconstructions of 
the confocal images using the line profile measurement module of the 
Volocity software. The Rac1 enrichment in actin tails represents the ratio 
between the maximum intensity value in the Rac1-GFP channel obtained 
from a line crossing a given actin tail and the maximum value from a line 
crossing the plasma membrane adjacent to the actin tail (see Fig. 6). 
PBD-PAK1 intensity was measured in cells coexpressing PBD-PAK1-DsRed 
and Rac1-GFP. The PBD-PAK1 enrichment at a given vaccinia tail or filopo-
dium base and tip was quantified in the PBD-PAK1-DsRed channel and rep-
resents the ratio between the intensity value for PBD-PAK1 at the maximum 
of Rac1 intensity measured in the blue channel and the corresponding 
value at the adjacent plasma membrane. Rac1 enrichment for the A36R 
virus variant was performed on samples stained for P-Src with mouse mono-
clonal antibody anti-P-Src (Tyr416; 1:200). Rac1 enrichment was quantified 
in the Rac1-DsRed channel on P-Src–positive viral particles, as described 
for wild-type virus.
Time-lapse video microscopy
HeLa cells were seeded on 35-mm imaging dishes (MatTek Corporation). 
Mock- and siRNA-treated cells were cotransfected with pYFP–N-WASP and 
actin CFP DNA constructs the day before infection with WR strain of 
vaccinia virus. Images were captured at 8–10 h after infection every 12 s 
on a spinning disc confocal microscope (TE2000E) using a 60× oil objec-
tive (NA 1.4) and the Volocity software. Tracking of N-WASP–tipped 
actin tails was performed using the tracking module of the Volocity soft-
ware. N-WASP–tipped actin tails tracked to calculate mean velocity were 
required to be motile for at least 60 s.
Statistical analysis
Quantitative analyses were performed in three independent experiments 
and 30–50 cells from 20 independent images were counted for each con-
dition. Quantifications on single viruses were performed on at least 500 
objects. Data are presented as mean ± SEM) and were analyzed by 
Student’s t test using Prism 5 (GraphPad Software).
Online supplemental material
Fig. S1 shows a time course of infection of vaccinia in control and ARPC4-
depleted cells, and the computer-assisted image analysis of spreading. 
Fig. S2 shows that FHOD1-depleted cells support L. monocytogenes actin- 
dependent dissemination. Fig. S3 shows the specificity of the recruitment of 
FHOD1 to vaccinia actin tails. Fig. S4 shows the enrichment of PBD-PAK1 
probe in vaccinia actin tails. Fig. S5 shows that Rac1-depleted cells sup-
port L. monocytogenes actin-dependent dissemination. Table S1 shows the 
sequences targeted by individual siRNA duplexes against FHOD1, RAC1, 
and PFN1. Table S2 shows the sequences of the oligonucleotides used in this 
study. Online supplemental material is available at http://www.jcb.org/ 
cgi/content/full/jcb.201303055/DC1.
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